Rethinking Territory Coverage When Reps Can't Get in the Door | NPLUS Global

The scenario below is a composite, built from patterns we've seen across pharma commercial teams — not a documented case study of any single company. It's meant to illustrate a problem that's become common enough to be worth unpacking honestly.

The Situation

A mid-size pharma manufacturer with a specialty portfolio — think a couple of branded products in a competitive therapeutic category — had built its commercial model the way most of the industry did for decades: geographic territories, a rep assigned to each, quotas tied to call frequency and reach. It worked fine for years because the underlying assumption held up — reps could generally get in front of the prescribers who mattered.

Then a meaningful share of that access went away. Not all at once, and not for dramatic reasons. A regional health system tightened its vendor credentialing policy and cut sample-drop visits to specialists. A large multi-specialty group moved to an appointment-only model that effectively capped rep visits to a handful of slots a month, shared across every manufacturer calling on that group. Several high-volume prescribers who used to take five-minute hallway meetings started declining reps altogether, routing everything through a portal or a medical affairs liaison instead.

None of this was unique to this manufacturer — it was happening across the market. But it hit their territory model hard, because their coverage plan assumed a level of physical access that simply wasn't there anymore in a growing number of accounts. Reps were still hitting their call-activity numbers on paper, but a widening share of those calls were low-value: waiting-room drop-ins, front-desk conversations, or repeat visits to the same easy-access prescribers because the harder ones weren't reachable at all.

What Didn't Work

The first instinct was to treat this as a productivity problem rather than a structural one. Management leaned on reps to "work harder" for access — more persistence, more creative scheduling, more relationship-building with office staff to get a foot in the door. That produced some marginal wins but didn't scale, and it burned out reps who were already frustrated at spending half their week on accounts that had made it clear they weren't interested.

The second attempt was to shift volume toward digital and remote detailing — webinars, email campaigns, virtual meeting requests — without changing much else about how territories were structured or how success was measured. This is where a lot of teams stall out. Swapping channel without rethinking segmentation just produces a different flavor of the same problem: reps (or marketing, depending on who owns the channel) blasting the same broad prescriber list with virtual outreach, regardless of whether those specific HCPs had shown any inclination to engage that way. Response rates were unremarkable, and the sales team treated the digital push as a stopgap rather than a real part of the model — something to do until access "came back."

It didn't come back, at least not to the accounts that had restricted it. That's the part worth sitting with: this wasn't a temporary disruption to plan around, it was a structural shift in how a meaningful chunk of the target list could be reached.

What Changed

The turning point was fairly unglamorous: the team stopped treating "the territory" as a single unit of coverage and started treating access itself as a variable that needed to be mapped, account by account and prescriber by prescriber, rather than assumed.

In practice that meant building a clearer picture of which accounts and individual HCPs were still reasonably reachable in person, which were restricted but responsive to virtual or peer-to-peer channels, and which had gone effectively dark to any manufacturer-initiated outreach. That picture came from a mix of sources — rep field notes, credentialing and vendor-access data, and prescribing and referral patterns that suggested where influence was actually happening even without direct rep contact. NPLUS Global's account and provider-level data was one input the team used to fill gaps in that picture, particularly for affiliations and system-level access changes that individual reps weren't always tracking consistently.

Once that segmentation existed, territory design and rep time allocation changed with it. High-access accounts kept a traditional field cadence. Restricted-but-responsive accounts got a blended plan — fewer in-person attempts, more scheduled virtual details, and closer coordination with medical science liaisons or peer-to-peer programs where those channels had actual credibility with the prescriber. Genuinely closed accounts were mostly pulled out of rep call plans altogether and handed to non-personal promotion — not because those prescribers stopped mattering, but because continuing to assign field time against a door that wasn't opening was just waste dressed up as effort.

This also meant changing what reps were measured on. Call volume against a flat territory list stopped being the primary metric. Instead, the team started tracking something closer to access-adjusted coverage — how much of the reachable, responsive portion of the territory was actually being worked well, rather than how many calls were logged against a list that hadn't been updated to reflect reality.

The Outcome

The results were incremental rather than transformative, and that's probably the honest way to describe most changes like this. Reps reported spending noticeably less time on dead-end visits and more time on conversations that went somewhere, which showed up first as improved morale and only later as improved productivity numbers. Marketing's virtual and non-personal channels stopped being an afterthought and started carrying real weight in accounts where they were the only viable path in, which took some pressure off the field team's numbers overall.

The bigger shift was cultural. The team stopped treating restricted access as a temporary annoyance to route around and started treating it as a permanent feature of the environment that needed to be built into how territories are designed, staffed, and measured from the outset. That reframing — access as data to be tracked and planned around, not an obstacle to be pushed through — is probably the more durable takeaway than any specific tactic they landed on.